Related references
Note: Only part of the references are listed.Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Christopher J. L. Murray et al.
LANCET (2022)
European Respiratory Society guidelines for the management of children and adolescents with bronchiectasis
Anne B. Chang et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
The immunomodulatory effects of macrolide antibiotics in respiratory disease
Jennifer Pollock et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2021)
Comparison of Profiles of First Nations and Non-First Nations Children With Bronchiectasis Over Two 5-Year Periods in the Northern Territory, Australia
Gabrielle B. McCallum et al.
CHEST (2021)
Clinical and research priorities for children and young people with bronchiectasis: an international roadmap
Anne B. Chang et al.
ERJ OPEN RESEARCH (2021)
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Dave P. Nichols et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Airway abundance of Haemophilus influenzae predicts response to azithromycin in adults with persistent uncontrolled asthma
Steven L. Taylor et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Cost of hospitalization for bronchiectasis exacerbation in children
Vikas Goyal et al.
RESPIROLOGY (2020)
Azithromycin Prescribing by Respiratory Pediatricians in Australia and New Zealand for Chronic Wet Cough: A Questionnaire-Based Survey
Naomi Chellew et al.
FRONTIERS IN PEDIATRICS (2020)
Quantifying Long-Term Changes in Lung Function and Exacerbations after Initiation of Azithromycin in Cystic Fibrosis
Angelique Denis et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2020)
Bronchiectasis phenotypes
Patricia Chang-Macchiu et al.
CURRENT OPINION IN PULMONARY MEDICINE (2019)
The microbiome in bronchiectasis
Hollian Richardson et al.
EUROPEAN RESPIRATORY REVIEW (2019)
British Thoracic Society Guideline for bronchiectasis in adults
Adam T. Hill et al.
THORAX (2019)
Ethnicity, socioeconomic status and the severity and course of non-cystic fibrosis bronchiectasis
Sally de Boer et al.
INTERNAL MEDICINE JOURNAL (2018)
Bronchiectasis: Treatment decisions for pulmonary exacerbations and their prevention
Scott C. Bell et al.
RESPIROLOGY (2018)
European Respiratory Society guidelines for the management of adult bronchiectasis
Eva Polverino et al.
EUROPEAN RESPIRATORY JOURNAL (2017)
Maturation of the Infant Respiratory Microbiota, Environmental Drivers, and Health Consequences
Astrid A. T. M. Bosch et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2017)
Long-term effects of azithromycin in patients with cystic fibrosis
Clementine Samson et al.
RESPIRATORY MEDICINE (2016)
Nasopharyngeal carriage and macrolide resistance in Indigenous children with bronchiectasis randomized to long-term azithromycin or placebo
K. M. Hare et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
Introduction to causal diagrams for confounder selection
Elizabeth J. Williamson et al.
RESPIROLOGY (2014)
Viral respiratory burden in moderate-to-late preterm infants
Louis Bont et al.
EARLY HUMAN DEVELOPMENT (2013)
Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial
Josje Altenburg et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Gestational Age, Birth Weight, and Risk of Respiratory Hospital Admission in Childhood
Shantini Paranjothy et al.
PEDIATRICS (2013)
Long-term azithromycin for Indigenous children with non-cystic-fibrosis bronchiectasis or chronic suppurative lung disease (Bronchiectasis Intervention Study): a multicentre, double-blind, randomised controlled trial
Patricia C. Valery et al.
LANCET RESPIRATORY MEDICINE (2013)
Azithromycin for Indigenous children with bronchiectasis: study protocol for a multi-centre randomized controlled trial
Patricia C. Valery et al.
BMC PEDIATRICS (2012)
Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial
Conroy Wong et al.
LANCET (2012)
Do New Zealand Children With Non-Cystic Fibrosis Bronchiectasis Show Disease Progression?
Karen A. Munro et al.
PEDIATRIC PULMONOLOGY (2011)
Retrospective review of children presenting with non cystic fibrosis bronchiectasis: HRCT features and clinical relationships
EA Edwards et al.
PEDIATRIC PULMONOLOGY (2003)
Non-CF bronchiectasis: Clinical and HRCT evaluation
AB Chang et al.
PEDIATRIC PULMONOLOGY (2003)
Share Paper
